Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Recruiting now

Conditions studied: Pulmonary Embolism and Thrombosis, Deterioration, Clinical, Artificial Intelligence

In brief

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.

Key facts

Study ID

NCT05482269

Run by

Shengjing Hospital

People needed

2000

Starts

2011-01-01

Expected to finish

2026-12-31

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography

You may not qualify if…

• pregnancy
• reception of reperfusion treatment before admission
• missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

Where it is running

• Shengjing Hospital — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.